GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.
LLMs were tested across 29 clinical scenarios, generating a total of 16,254 responses. The PrIME-LLM scores ranged from 0.64 ...
Luna, an AI agent developed by San Francisco startup Andon Labs, has officially transitioned from a software tool to a retail ...
A Hezbollah attack has killed a French soldier, raising questions about the Lebanon ceasefire’s durability. The ...
Israeli artillery fire in southern Lebanon has undermined the ceasefire agreement brokered on April 16. The Israel x ...
APi Group activity within the NYSE Composite highlights trading volume trends, specialty contracting services, and ...
AI reasoning does not necessarily require spending huge amounts on frontier models. Instead, smaller models can yield ...
Staying flexible with technology requires a commitment to constant evolution—continually testing new initiatives, adopting ...
Srinivas Narayanan, chief technology officer of business-to-business (B2B) applications at American AI company OpenAI, ...
When Anthropic quietly told a small group of cybersecurity firms in early April 2026 that it had built an AI tool capable of ...
Anthropic released a new model, Opus 4.7. Some users on X and Reddit aren't happy, calling it "dumb" and more costly on ...
Market analysis reveals that around 65% of UK enterprises now consider system integration a core strategy for boosting ...